Report Code : CVMI160520251 | Published Date : May 16, 2025

The Swine Parasiticide Market is gaining renewed importance as internal and external parasites continue to affect swine health, growth rates, and reproductive efficiency. From gastrointestinal nematodes to manage mites and lice, parasitic infestations inflict significant economic losses in pork production. The global market for swine parasiticides is estimated at USD 920 million in 2024 and is projected to reach USD 1.35 billion by 2031, growing at a CAGR of 5.5%. Increased awareness of herd hygiene, improved diagnostics, and the demand for drug resistance management are driving product development and adoption.

Key Market Drivers

Economic Loss Prevention: Subclinical parasitic infestations reduce average daily gain (ADG) and feed conversion ratio (FCR), leading to hidden productivity losses.

Drug Resistance Concerns: Misuse and overuse of anthelmintics have led to resistance in major helminths, prompting rotation protocols and combination treatments.

Focus on Welfare Standards: Retailers and regulators increasingly mandate parasite control as part of animal welfare certification schemes.

Market Segmentation

By Product Type

  • Endoparasiticides (XX%): Dewormers including benzimidazoles, macrocyclic lactones
  • Ectoparasiticides (25%): Pour-ons, sprays, injectables for lice and mange
  • Combination Products (XX%): Broad-spectrum formulations combining internal and external action

By Route of Administration

  • Oral (XX%): Medicated feed and drenches
  • Injectable (30%): Controlled-dose ivermectins and doramectin products
  • Topical (XX%): Pour-on and spray-on solutions

By End User

  • Commercial Farms (XX%)
  • Veterinary Clinics (15%)
  • Backyard/Pasture-Based Operations (XX%)

Competitive Landscape

The market is dominated by established animal health players and specialty parasiticide manufacturers:

  • Boehringer Ingelheim – Ivomec® and LongRange® for extended parasite protection
  • Zoetis – Dectomax® injectables and combination formulations
  • Elanco Animal Health – Safe-Guard® and topical parasite solutions
  • Norbrook Laboratories – High-quality generic ivermectins and levamisole

Emerging Trends

Resistance Surveillance Programs: On-farm fecal egg count monitoring is being encouraged by veterinary networks to ensure effective treatment protocols.

Natural and Organic Dewormers: Botanical and phytogenic dewormers are gaining popularity among organic swine producers.

Long-Acting Injectable Formulations: Innovations in slow-release delivery systems are reducing the need for frequent reapplication.

Integrated Parasite Management (IPM): Combines hygiene, rotational grazing (in outdoor systems), and strategic dosing to lower reliance on chemicals.

Regulatory Landscape

Global agencies are updating MRL maximum residue limit guidelines for meat safety. In Europe, zero-residue parasite treatments are preferred. In the U.S., prescription-only regulations are expanding for certain parasiticides. Many Asian nations are enforcing stricter withdrawal periods and resistance tracking requirements.






Reasons To Buy

Image



Scope

Image
  • Zoetis Inc.
  • Boehringer Ingelheim 
  • Elanco Animal Health 
  • Merck Animal Health 
  • Bayer Animal Health 
  • Virbac 
  • Ceva Santé Animale 
  • Vetoquinol S.A
  • Huvepharma
  • Norbrook Laboratories Ltd
Image